...
首页> 外文期刊>Aging cell. >Knockdown of astrocytic Grin2a aggravates β-amyloid-induced memory and cognitive deficits through regulating nerve growth factor
【24h】

Knockdown of astrocytic Grin2a aggravates β-amyloid-induced memory and cognitive deficits through regulating nerve growth factor

机译:星形胶质细胞粗糙度敲击通过调节神经生长因子来加剧β-淀粉样蛋白诱导的记忆和认知缺陷

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Synapse degeneration correlates strongly with cognitive impairments in Alzheimer's disease (AD) patients. Soluble Amyloid-beta (Aβ) oligomers are thought as the major trigger of synaptic malfunctions. Our earlier studies have demonstrated that Aβ oligomers interfere with synaptic function through N-methyl-D-aspartate receptors (NMDARs). Our recent in vitro study found the neuroprotective role of astrocytic GluN2A in the promotion of synapse survival and identified nerve growth factor (NGF) derived from astrocytes, as a likely mediator of astrocytic GluN2A buffering against Aβ synaptotoxicity. Our present in vivo study focused on exploring the precise mechanism of astrocytic GluN2A influencing Aβ synaptotoxicity through regulating NGF. We generated an adeno-associated virus (AAV) expressing an astrocytic promoter (GfaABC1D) shRNA targeted to Grin2a (the gene encoding GluN2A) to perform astrocyte-specific Grin2a knockdown in the hippocampal dentate gyrus, after 3?weeks of virus vector expression, Aβ were bilaterally injected into the intracerebral ventricle. Our results showed that astrocyte-specific knockdown of Grin2a and Aβ application both significantly impaired spatial memory and cognition, which associated with the reduced synaptic proteins PSD95, synaptophysin and compensatory increased NGF. The reduced astrocytic GluN2A can counteract Aβ-induced compensatory protective increase of NGF through regulating pNF-κB, Furin and VAMP3, which modulating the synthesis, mature and secretion of NGF respectively. Our present data reveal, for the first time, a novel mechanism of astrocytic GluN2A in exerting protective effects on synapses at the early stage of Aβ exposure, which may contribute to establish new targets for AD prevention and early therapy.
机译:Synapse变性与阿尔茨海默病(AD)患者的认知障碍强烈相关。可溶性淀粉样蛋白β(Aβ)低聚物被认为是突触故障的主要触发。我们之前的研究表明,Aβ低聚物通过N-甲基-D-天冬氨酸受体(NMDARS)干扰突触函数。我们最近的体外研究发现星形胶质细胞的神经保护作用在促进突触生存和鉴定的神经细胞衍生的神经生长因子(NGF)中,作为星形胶质细胞的可能介导缓冲Aβ突触毒性。我们的存在于Vivo研究中,专注于通过调节NGF来探索影响Aβ突触毒性的星形胶质细胞的精确机制。我们生成了表达靶向半胶质细胞启动子(GFAABC1D)shRNA的腺相关病毒(AAV)靶向GRIN2A(编码GLUN2A),以在病毒载体表达的3个〜3周后在海马齿状齿状齿轮中进行半织物特异性Grin2a敲低,Aβ双侧被注射到脑室内脑室。我们的研究结果表明,Grin2a和Aβ应用的星形胶质细胞特异性敲低的空间记忆和认知均具有显着减弱的空间记忆和认知,其与降低的突触蛋白PSD95,突触蛋白和补偿性增加NGF相关。减少的星形胶质细胞GLUN2A可以通过调节PNF-κB,FURIN和VAMP3来抵消NGF的Aβ诱导的补偿性保护性分别调节NGF的合成,成熟和分泌。我们目前的数据首次揭示了星形胶质细胞GLUN2A的新机制,以施加对Aβ暴露早期突触突触的保护作用,这可能有助于建立广告预防和早期治疗的新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号